Genetische Präimplantationsdiagnostik (PID)

Genetische Präimplantationsdiagnostik (PID)

At Gynolife IVF Center we offer Preimplantation Genetic Diagnosis (PGD) to couples who carry known genetic disorders or have previously experienced child loss due to genetic conditions. PGD is an advanced laboratory technique used during IVF treatment to examine embryos for specific genetic diseases or chromosomal abnormalities before they are transferred to the uterus. This allows only genetically healthy embryos to be selected for transfer - significantly reducing or eliminating the risk of passing the genetic disorder to the child.

PGD is especially recommended for couples carrying single gene disorders (such as Thalassemia - Cystic Fibrosis - Sickle Cell Anemia - Huntington Disease) - structural chromosomal abnormalities (translocations - inversions) - families who have previously had a child with a genetic condition or those requiring HLA-compatible siblings. This method is a revolutionary step in helping couples achieve their dream of having a healthy baby and preventing genetic diseases from being passed to future generations.

At Gynolife IVF Center the PGD process begins with a thorough evaluation of the couple genetic status and development of a customized PGD test. Following standard IVF/ICSI treatment eggs are collected and fertilized. When embryos reach the blastocyst stage (usually day 5 or 6) a few cells are carefully biopsied without harming the embryo. Advanced molecular genetic tests (such as PCR - FISH - NGS) are performed on these cells targeting the specific genetic disease or chromosomal anomaly. Embryos confirmed as genetically healthy are then selected for transfer to the intended mother uterus.

Warum die PID?

• Eliminates or significantly reduces the risk of passing hereditary genetic diseases to your child
• Provides definitive diagnosis and healthy embryo selection for known single gene disorders like Thalassemia and Cystic Fibrosis
• Enables couples carrying chromosomal structural abnormalities to have healthy children
• Allows selection of unaffected embryos when there is a family history of genetic disease
• Can assist with HLA-compatible sibling selection for bone marrow transplant needs
• May prevent genetically-caused recurrent pregnancy losses
• Significantly increases the chance of a healthy pregnancy and healthy baby